Leena Chacko’s Post

View profile for Leena Chacko, graphic

Senior Associate Scientist at MESO SCALE DIAGNOSTICS, LLC.

I am very much delighted to share our publication in the journal Drug Discovery Today, https://lnkd.in/enq8HCwP "#CRISPR-Cas9 in Alzheimer’s disease: #Therapeutic trends, modalities, and challenges" resulting from our collaboration with Anupama Chaudhary, Birbal Singh, Saikat Dewanjee, Ramesh Kandimalla. This research paper explores the potential of CRISPR-Cas9 as a therapeutic tool for #Alzheimer's disease (AD), focusing on the current trends, modalities, and challenges associated with its application. #crisprmedicinenews #pharma #geneediting #alzheimers #alzheimersdisease #celltherapy #cellandgenetherapy

CRISPR-Cas9 in Alzheimer's disease: Therapeutic trends, modalities, and challenges. | ALZFORUM

CRISPR-Cas9 in Alzheimer's disease: Therapeutic trends, modalities, and challenges. | ALZFORUM

alzforum.org

Sangeeta Bade

Bioanalytical Scientist at MESO SCALE DIAGNOSTICS, LLC.

1y

congratulations

Like
Reply
Ramesh Kandimalla

DBT-Ramalingaswami Fellow/ Assistant Professor-AcSIR

1y

Congratulations 🎉

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics